KORU Medical Systems (NASDAQ:KRMD) Announces Quarterly Earnings Results

KORU Medical Systems (NASDAQ:KRMD) issued its quarterly earnings data on Wednesday. The company reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.01, Zacks reports. The business had revenue of $10.40 million for the quarter, compared to analysts’ expectations of $9.67 million. KORU Medical Systems had a negative net margin of 12.24% and a negative return on equity of 26.77%. KORU Medical Systems updated its FY 2025 guidance to EPS.

KORU Medical Systems Trading Up 1.3%

Shares of KRMD stock opened at $3.78 on Thursday. KORU Medical Systems has a 1-year low of $1.86 and a 1-year high of $5.05. The company has a market cap of $174.77 million, a price-to-earnings ratio of -42.00 and a beta of 0.42. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.91 and a quick ratio of 2.25. The stock has a 50 day simple moving average of $4.01 and a 200-day simple moving average of $3.62.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of KORU Medical Systems in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $4.63.

Hedge Funds Weigh In On KORU Medical Systems

A number of large investors have recently added to or reduced their stakes in the stock. Lazard Asset Management LLC purchased a new position in KORU Medical Systems during the second quarter valued at $59,000. Acadian Asset Management LLC acquired a new position in shares of KORU Medical Systems during the 1st quarter worth about $63,000. Invesco Ltd. purchased a new position in KORU Medical Systems in the 2nd quarter valued at about $80,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in KORU Medical Systems in the 2nd quarter worth about $83,000. Finally, New York State Common Retirement Fund acquired a new stake in KORU Medical Systems in the 2nd quarter worth about $100,000. 58.60% of the stock is currently owned by institutional investors and hedge funds.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.